This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Lung Cancer
  • /
  • MA26.06 Crizotinib-Treated ALK Immunopositive Meta...
Journal

MA26.06 Crizotinib-Treated ALK Immunopositive Metastasized NSCLC is Associated with an Unfavorable Prognosis when FISH Negative

Read time: 1 mins
Published:30th Sep 2018
Author: Thunnissen E, Lissenberg-Witte B, Van Den Heuvel M, Monkhorst K, Skov B, Sorensen J, et al.
Availability: Free full text
Ref.:J Thorac Oncol. 2018;13(10):S452.
DOI:10.1016/j.jtho.2018.08.542
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest